Article
Clinical Neurology
Orhan Aktas, Michael A. Smith, William A. Rees, Jeffrey L. Bennett, Dewei She, Eliezer Katz, Bruce A. C. Cree
Summary: High serum GFAP concentration may be associated with NMOSD activity and attack risk, and may reflect treatment effects.
ANNALS OF NEUROLOGY
(2021)
Article
Immunology
Yun-Fan You, Man Chen, Yue Tang, Wen-Xiang Yu, Xiao-Wei Pang, Yun-Hui Chu, Hang Zhang, Ke Shang, Gang Deng, Luo-Qi Zhou, Sheng Yang, Wei Wang, Jun Xiao, Dai-Shi Tian, Chuan Qin
Summary: Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune inflammatory demyelinating disease of the central nervous system (CNS). TREM2, expressed by microglia, plays a crucial role in microglial activation and function during NMOSD demyelination.
JOURNAL OF NEUROINFLAMMATION
(2023)
Review
Medicine, General & Internal
Yachinee Naphattalung, Wanicha Leetiratanai Chuenkongkaew, Niphon Chirapapaisan, Poramaet Laowanapiban, Supattra Sawangkul
Summary: The current data from this systematic review are insufficient to conclude definitively whether therapeutic plasma exchange (PLEX) is effective in improving visual acuity in cases of neuromyelitis optica (NMO) or neuromyelitis optica spectrum disorder (NMOSD). The objective of this study was to evaluate whether PLEX effectively improves visual function for acute optic neuritis (ON) in NMO or NMOSD. Twelve studies were included in the analysis, but the data were inconclusive in determining the effectiveness of PLEX for treating acute ON in NMO/NMOSD.
ANNALS OF MEDICINE
(2023)
Article
Clinical Neurology
Juan Esteban Cote-Orozco, Natalia Velez-Tirado
Summary: A 10-year-old girl presented with symptoms of excessive daytime sleepiness, sudden sleep onset, hypnagogic hallucinations, hyporexia, and behavioral changes. MRI examination revealed bilateral hypothalamic lesion. Positive AQP4 -IgG antibodies were found in serum and low hypocretin levels in the CSF. The diagnosis was narcolepsy secondary to neuromyelitis optica spectrum disorder.
Review
Clinical Neurology
Sara Bagherieh, Alireza Afshari-Safavi, Saeed Vaheb, Mahsa Kiani, Elham Moases Ghaffary, Mahdi Barzegar, Vahid Shaygannejad, Aram Zabeti, Omid Mirmosayyeb
Summary: This systematic review and meta-analysis aimed to estimate the prevalence and incidence rates of NMOSD/NMO worldwide. The analysis showed that the rates varied and were higher among females. More large-scale studies are needed to fully understand the epidemiological aspects of these conditions.
NEUROLOGICAL SCIENCES
(2023)
Article
Clinical Neurology
Frederike Cosima Oertel, Svenja Specovius, Hanna G. Zimmermann, Claudia Chien, Seyedamirhosein Motamedi, Charlotte Bereuter, Lawrence Cook, Marco Aurelio Lana Peixoto, Mariana Andrade Fontanelle, Ho Jin Kim, Jae-Won Hyun, Jacqueline Palace, Adriana Roca-Fernandez, Maria Isabel Leite, Srilakshmi Sharma, Fereshteh Ashtari, Rahele Kafieh, Alireza Dehghani, Mohsen Pourazizi, Lekha Pandit, Anitha D'Cunha, Orhan Aktas, Marius Ringelstein, Philipp Albrecht, Eugene May, Caryl Tongco, Letizia Leocani, Marco Pisa, Marta Radaelli, Elena H. Martinez-Lapiscina, Hadas Stiebel-Kalish, Sasitorn Siritho, Jerome de Seze, Thomas Senger, Joachim Havla, Romain Marignier, Alvaro Cobo Calvo, Denis Bichuetti, Ivan Maynart Tavares, Nasrin Asgari, Kerstin Soelberg, Ayse Altintas, Rengin Yildirim, Uygur Tanriverdi, Anu Jacob, Saif Huda, Zoe Rimler, Allyson Reid, Yang Mao-Draayer, Ibis Soto de Castillo, Axel Petzold, Ari J. Green, Michael R. Yeaman, Terry Smith, Alexander U. Brandt, Friedemann Paul
Summary: This study highlights the importance of attack prevention to avoid severe neuroaxonal damage and vision loss caused by ON in NMOSD. Therapies to ameliorate attack-related damage, especially during the first attack, are a clinical need. Mild neuroaxonal changes in ON-unaffected eyes may be solely due to contralateral ON attacks and do not indicate clinically relevant progression, but require further investigation.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION
(2021)
Review
Clinical Neurology
Trygve Holmoy, Rune Alexander Hoglund, Zsolt Illes, Kjell-Morten Myhr, Oivind Torkildsen
Summary: For NMOSD patients, monoclonal antibodies that deplete B cells or interfere with interleukin 6 signaling have superior efficacy compared to placebo; Rituximab, tocilizumab, and to some extent eculizumab have well-known safety profiles; Rituximab and azathioprine may be safe during pregnancy.
JOURNAL OF NEUROLOGY
(2021)
Review
Immunology
Soudeh Ghafouri-Fard, Tahereh Azimi, Mohammad Taheri
Summary: Neuromyelitis optica spectrum disorders are mainly characterized by optic neuritis and myelitis, with both familial and sporadic forms observed. Certain HLA haplotypes have been associated with familial NMO, while some specific alleles within HLA-DRB1 are linked to sporadic NMO. Genome-wide SNP arrays have identified susceptible loci for NMO in recent studies.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Immunology
Daidi Zhao, Kaixi Ren, Jiarui Lu, Zhiqin Liu, Zunbo Li, Jun Wu, Zhihao Xu, Songdi Wu, Tao Lei, Chao Ma, Sijia Zhao, Miao Bai, Hongzeng Li, Jun Guo
Summary: This study evaluated the efficacy and safety of a lower-dose rituximab (RTX) therapy for neuromyelitis optica spectrum disorder (NMOSD) based on a multicenter, open-label, prospective follow-up study. The results demonstrated that the lower-dose RTX strategy significantly reduced relapse rate, improved disability score, and decreased spinal cord lesion. Early therapy initiation showed better outcomes compared to delayed therapy.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Clinical Neurology
Juan Zhang, Mei-Jiao Chen, Gui-Xian Zhao, Hong-Fu Li, Lei Wu, Yong-Feng Xu, Yajin Liao, Zengqiang Yuan, Zhi-Ying Wu
Summary: The study explored the association between PRRC2A variants and susceptibility to NMOSD and MS in the Han Chinese population. Certain PRRC2A variants were found to alter susceptibility to AQP4(+)NMOSD and MS, with specific genotypes increasing the risk. Additionally, haplotypes and gene expression levels associated with these variants were identified, suggesting potential implications for personalized therapeutic approaches in these disease entities.
JOURNAL OF NEUROLOGY
(2021)
Article
Immunology
Yasunobu Hoshino, Daisuke Noto, Shuhei Sano, Yuji Tomizawa, Kazumasa Yokoyama, Nobutaka Hattori, Sachiko Miyake
Summary: This study demonstrates that B cells in patients with NMOSD are abnormally skewed towards antibody-secreting cells at the transcriptome level during the early differentiation phase, and IL-2 might participate in this pathogenic process. CD25(+) naive B cells are identified as a novel candidate precursor of antibody-secreting cells in autoimmune diseases.
JOURNAL OF NEUROINFLAMMATION
(2022)
Article
Immunology
Yue Su, Zhe Ruan, Shicao Li, Zhuyi Li, Ting Chang
Summary: This study conducted a bibliometric analysis of publications on NMOSD, revealing its hotspots and development trends. The United States published the most literature and made significant contributions. The current research hotspots may focus on efficacy, multicenter, interleukin-6 receptor blockade, safety, azathioprine, tolerance, and adult.
FRONTIERS IN IMMUNOLOGY
(2023)
Article
Neurosciences
Bo-Wen Yin, Bin Li, Arshad Mehmood, Congcong Yuan, Shuang Song, Ruo-Yi Guo, Lu Zhang, Tianzhao Ma, Li Guo
Summary: This study found that the minor allele G of rs2248932 in the BLK gene is associated with reduced susceptibility to NMOSD and provides protection for AQP4-positive patients. BLK mRNA expression levels were lower in NMOSD patients compared to healthy controls, but significantly higher in acute-untreated patients.
CNS NEUROSCIENCE & THERAPEUTICS
(2021)
Article
Clinical Neurology
Konrad Rejdak, Ewa Papuc
Summary: Cladribine treatment was safe and effective in patients with NMOSD over a 24-month period, resulting in a significant decrease in annualized relapse rate and no progression of disability status.
EUROPEAN JOURNAL OF NEUROLOGY
(2021)
Article
Immunology
Liang Wang, Lei Du, Qinying Li, Fang Li, Bei Wang, Yuanqi Zhao, Qiang Meng, Wenyu Li, Juyuan Pan, Junhui Xia, Shitao Wu, Jie Yang, Heng Li, Jianhua Ma, Jingzi ZhangBao, Wenjuan Huang, Xuechun Chang, Hongmei Tan, Jian Yu, Lei Zhou, Chuanzhen Lu, Min Wang, Qiang Dong, Jiahong Lu, Chongbo Zhao, Chao Quan
Summary: This study investigates the predictors of relapse, and severe visual or motor disability in patients with NMOSD and develops corresponding predictive models. Early identification of patients at risk of unfavorable outcomes is crucial for informing treatment decisions.
FRONTIERS IN IMMUNOLOGY
(2022)